Skip to main content

Month: June 2024

Patria Signs Agreement to Acquire Nexus Capital, Further Expanding its Real Estate Platform in Colombia

Transaction advances Patria’s efforts to consolidate the region’s fragmented Real Estate market by adding a diversified and well-established platform in Colombia with approximately US$ 800 million in assets under management across multiple strategies GRAND CAYMAN, Cayman Islands, June 06, 2024 (GLOBE NEWSWIRE) — Patria Investments Limited (“Patria”) (NASDAQ: PAX), a global alternative asset manager and market leader in Latin America, announced today an agreement to acquire Nexus Capital (“Nexus”), one of the top independent alternative real estate asset managers in Colombia, with approximately US$ 800 million in assets under management (“AUM”) across multiple strategies. Upon the completion of the acquisition of 100% of Nexus, Patria’s Real Estate AUM in Colombia will be over US$ 2.2 billion. The transaction is expected to...

Continue reading

Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Listing Social Engagement Event

WARREN, N.J., June 06, 2024 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), is a clinical-stage specialty immunotherapy company harnessing one of nature’s most powerful immunological weapons, CD8+ cytotoxic T lymphocytes (“CD8+ CTLs”), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders with the aim of addressing the significant unmet needs of large patient populations. Tevogen Bio, founded by a group of pioneering industry leaders and distinguished scientists with extensive drug development and global product launch experience, aims to chart the next frontier of medicine, where disruptive science and innovative business models pave the way to a healthier future for all, centered on the concept that sustainable...

Continue reading

Brilliant Earth Announces Participation in Sidoti Small Cap Conference, SHARE Series at NYSE, and Jefferies Consumer Conference

SAN FRANCISCO, June 06, 2024 (GLOBE NEWSWIRE) — Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced that the Company will participate in upcoming investor events. On June 12, 2024, the Company will participate in the Sidoti Small Cap Conference being held virtually. Management will hold a presentation at 4:00pm ET and host investor meetings throughout the day. On June 14, 2024, the Company will participate in the SHARE Series event being held at the New York Stock Exchange. Management will participate in a fireside chat presentation at 9:00am ET. From June 17th to June 18th, 2024, the Company will participate in the Jefferies Consumer Conference being held in Nantucket, Massachusetts. Management will hold a breakout session...

Continue reading

Xtract One Announces Third Quarter Fiscal 2024 Results

Record Quarterly Revenue; $9.5 Million in New Bookings; Outlook Remains Strong TORONTO, June 06, 2024 (GLOBE NEWSWIRE) — Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) a leading technology-driven threat detection and security solution that prioritizes the patron access experience by leveraging AI, today announced fiscal third quarter results for the three and nine months ended April 30, 2024. All information is in Canadian dollars unless otherwise indicated. Third Quarter Financial HighlightsRecord revenue of $4.7 million for the three months ended April 30, 2024 versus $0.9 million in the prior-year period.Gross margin for the Platform operating segment of 60% for the third quarter unchanged from the same period last year.Announced new customer wins during the quarter including...

Continue reading

Saputo Reports Fourth Quarter and Fiscal 2024 Results

MONTRÉAL, June 06, 2024 (GLOBE NEWSWIRE) — Saputo Inc. (TSX: SAP) (we, Saputo or the Company) reported today its financial results for the fourth quarter and fiscal year ended on March 31, 2024. All amounts in this news release are in millions of Canadian dollars (CDN), except per share amounts, unless otherwise indicated, and are presented according to International Financial Reporting Standards (IFRS). Commenting on full-year results, Lino A. Saputo, Chair of the Board, President and CEO, said: “Fiscal 2024 was a year of continued resilience. Our financial performance reflected our ability to stay the course even amidst a dynamic macro-economic environment which included commodity price volatility, a challenged consumer, and ongoing inflationary pressures. It was also a year of continued progress where, after three years of investing...

Continue reading

Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

SARASOTA, FL, June 06, 2024 (GLOBE NEWSWIRE) — SARASOTA, FL, June 6, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 917,432 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $2.18 per share (or per common stock equivalent in lieu thereof). In a concurrent private placement, the Company issued unregistered warrants to purchase up to 917,432 shares of common stock at an exercise price of $2.06 per share that are immediately exercisable...

Continue reading

Priority Income Fund Announces Declaration of Preferred Stock Distributions for June 2024

NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) — Priority Income Fund, Inc. (“Priority Income Fund” or the “Fund”) announced today the declaration of distributions on shares of the Fund’s 7.00% Series D Term Preferred Stock due 2029 (“Series D”), 6.625% Series F Term Preferred Stock due 2027 (“Series F”), 6.250% Series G Term Preferred Stock due 2026 (“Series G”), 6.000% Series H Term Preferred Stock due 2026 (“Series H”), 6.125% Series I Term Preferred Stock due 2028 (“Series I”), 6.000% Series J Term Preferred Stock due 2028 (“Series J”), 7.000% Series K Cumulative Preferred Stock (“Series K”), and 6.375% Series L Term Preferred Stock due 2029 (“Series L”).  Ex-Dividend Date Record Date Payable Date Distribution per ShareSeries D June 20, 2024 June 21, 2024 June 28, 2024 $0.43750Series F June 20, 2024 June 21, 2024 June 28,...

Continue reading

BrightSpring Awards Brighter Futures Scholarship and Hospice Nursing Scholarship to Help Five Louisville Students Pursue Healthcare Careers

LOUISVILLE, Ky., June 06, 2024 (GLOBE NEWSWIRE) — BrightSpring Health Services, (“BrightSpring” or “BrightSpring Health Services“) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex health populations, is proud to continue to support high-potential and under-reached students by facilitating their ongoing academic advancement through the annual BrightSpring Brighter Futures Scholarship and BrightSpring Hospice Nursing Scholarship. This year, BrightSpring has selected Layah Hodges of Louisville, Kentucky, as the recipient of the 2024 Brighter Futures Scholarship. The Company has also awarded the Hospice Nursing Scholarship to the following four students from Louisville: Morgan Harper, Chasta May, Samyah Edwards, and Onileola Ilesanmi.  “We are excited to award this year’s scholarships...

Continue reading

ProStar Holdings Announces Closing of Final Tranche of Private Placement For Gross Proceeds of C$1.1M

GRAND JUNCTION, Colo., June 06, 2024 (GLOBE NEWSWIRE) — (OTCQB: MAPPF) (TSXV: MAPS) (FSE: 5D00) ProStar Holdings Inc. (the “Company” or “ProStar®“) a world leader in Precision Mapping Solutions®, is pleased to announce that it has closed the final tranche of its previously announced non-brokered private placement (the “Offering”) for gross proceeds of approximately C$1.1 million, through the sale of 6,944,466 units (the “Units”) at a price of C$0.16 per Unit (the “Offering Price”). Further to the Company’s news releases dated March 13, 2024, March 27, 2024 and May 14, 2024, the Company has raised gross proceeds of approximately C$2.5 million through the sale of 15,689,212 Units in the Offering. Each Unit consists of one common share of the Company (each, a “Common Share”, and collectively...

Continue reading

Quanex Building Products Announces Second Quarter 2024 Results and Reaffirms Full Year 2024 Guidance

Margin Expansion in North America and on a Consolidated BasisRepaid $10 Million in Bank Debt – No Outstanding Draws on RevolverTyman Acquisition Expected to Close in 2H24 HOUSTON, June 06, 2024 (GLOBE NEWSWIRE) — Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended April 30, 2024.   The Company reported the following selected financial results:  Three Months Ended April 30,   Six Months Ended April 30,($ in millions, except per share data) 2024   2023   2024   2023Net Sales $266.2   $273.5   $505.4   $535.5Gross Margin $66.2   $67.2   $117.7   $118.9Gross Margin % 24.9%   24.6%   23.3%   22.2%Net Income $15.4   $21.5   $21.6   $23.4Diluted EPS $0.46   $0.65   $0.65   $0.71               Adjusted Net Income $21.8   $21.7   $27.6   $27.8Adjusted...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.